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associations (at least for rhinovirus 
and influenza A), we consider that 
these results reflect what is statistically 
anticipated. Importantly, we notice 
that these considerations were also 
missing from another study on the 
same topic published in 2019.2 
Our comment on the interpretation 
of the clinical data in the study by Wu 
and colleagues1 does not argue against 
the existence of viral interference. 
However, a study published in 2019 
showed that influenza A blocked 
rhinovirus replication, but that 
rhinovirus did not interfere with 
influenza A virus replication in vitro.3 
These results contradict the in-vitro 
data presented by Wu and colleagues,1 
and these opposing conclusions 
highlight the difficulties in translating 
experimental observations to a clinical 
setting.
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individuals gives an expected 
number of 200 × 200/800=50. Such a 
calculation leads to the conclusion that 
the observed number (n=4) is lower 
than the expected number (n=50); the 
odds ratio would be 0·042. 
This approach was applied in the 
study by Wu and colleagues,1 in which 
they collected data only from patients 
with symptoms, and calculated the 
expected number of individuals co-
infected with rhinovirus and influenza 
A virus as 989 × 922/13 707=67. Based 
on this calculation, they concluded 
that the observed number of co-
infections (n=12) was significantly 
lower than the expected number 
(n=67). As shown in the above 
example, this conclusion is not 
justified, and the mistake illustrates 
that calculating the expected number 
of co-infections from observations 
in datasets including only individuals 
with symptoms is misleading, as 
pathogens that are truly independent 
in the population by such a calculation 
will appear to be negatively associated 
with each other (ie, occur as a co-
infection less often than expected). 
To provide another example, we 
compared data from the study by 
Wu and colleagues1 with that of an 
ongoing study of 8178 samples 
referred for testing of respiratory 
pathogens by a multiplex PCR panel at 
our centre, over the course of 1 year. As 
shown in supplementary figure 1B and 
C (appendix), negative associations 
were observed when the co-infection 
frequency was compared with the 
frequency of infection with each virus 
alone, not only for rhinovirus and 
influenza A, but also for several virus 
pairs. Although Wu and colleagues1 
concluded that viral interference 
was responsible for these negative 
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In the study by Anchi Wu and 
colleagues,1 the authors claim that 
rhinovirus reduces susceptibility to 
influenza A virus through a mechanism 
known as viral interference, basing 
their conclusions on viral detection 
rates in clinical samples and in-vitro 
experiments. We agree that viral 
interference might contribute to 
a reduction in the number of co-
infections. However, this conclusion 
cannot be drawn from their data, 
as calculating the expected number 
of co-infections in a sample of non-
randomly selected patients is not 
statistically accurate. 
To exemplify this point, assume 
that two viruses, X and Y, both with 
a prevalence of infection of 2%, were 
independently present in a population 
of 10 000 individuals, and that all 
individuals had samples taken on 
the same day. We then expect to find 
10 000 × 0·02 × 0·02=4 individuals 
infected with both viruses, and 
196 individuals each infected 
with either X or Y viruses. Further 
assume that, of 800 individuals with 
symptoms, 404 carry pathogens other 
than X or Y. Supplementary figure 1A 
(appendix) shows contingency tables 
with the expected number of 
individuals in the whole population and 
in the symptomatic population infected 
with X, Y, X and Y, or neither. Calculation 
of the expected number of individuals 
co-infected with X and Y from the 
contingency table of  symptomatic 
See Online for appendix
